Stira Pharmaceuticals is a sterile injectable CDMO with integrated analytical capabilities and extensive pharmaceutical product development experience. Our team of experienced scientists develops and supports the commercialization of complex injectable products using in-house technologies, established processes, and deep technical expertise.
Our Flagship Capabilities:
- Comprehensive contract analytical services
- Analytical R&D and end-to-end product development for small molecules, peptides, oligonucleotides, and large-molecules (including biosimilars)
- Three injectable robotic fill-and-finish lines using RTU components
- Diverse sterile injectable formats (vials, syringes, IV bags, cartridges)
- In-house stability program, analytical labs and robust regulatory support
